Clinical Trials Directory

Trials / Unknown

UnknownNCT04245007

Effect of Intermittent Fasting on Fat Mass

Effect of 8 Weeks 5:2 Intermittent Fasting on Fat Mass Among Obese Male Students Aged 18-25 in Indonesia University

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
62 (estimated)
Sponsor
Indonesia University · Academic / Other
Sex
Male
Age
18 Years – 25 Years
Healthy volunteers
Not accepted

Summary

This study is aimed to assess the different effect on fat mass between fasting (intervention) group and not fasting (control) group after 8 weeks 5:2 intermittent fasting (IF) among obese male student aged 18-25. Female students are excluded because if they do any restriction intake during their menstruation period which is a lot of blood lost, it will be a risk for them. This study is designed as non-blinding randomized control trial. Subject who adhere with less than 85 percent fasting (14 out of 16) will be dropped out from this study. Total sample in this study is 62 students which are 31 students for each group.

Detailed description

5:2 intermittent fasting (IF) is eating pattern in which no or few calories are consumed for 13 hours (for 5 am to 6 pm) done in two non-consecutive days days per week, followed by ad libitum intake on the remaining days, without any requirement of water restriction. Subjects will be distributed to each group by using randomization block of four. This study will use 8 forms consist of; informed consent, subject selection form, re-anthropometric measurement form, questionnaire, semi quantitative food frequency questionnaire (SQ-FFQ), international physical activity questionnaire (IPAQ), food record book, and control and evaluation form. While the tolls are consist of food photograph book (to help in filling the food record book), body height scale, and bio-electrical impedance analysis (BIA) Seca medical body composition analyzer (mBCA) 515/514 (to measure body composition).

Conditions

Interventions

TypeNameDescription
BEHAVIORALFastingDoing fasting 2 days a week within 8 weeks

Timeline

Start date
2020-01-27
Primary completion
2020-04-09
Completion
2020-04-09
First posted
2020-01-28
Last updated
2020-01-28

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT04245007. Inclusion in this directory is not an endorsement.